Stewart Scott H, Connors Gerard J
Center for Drug and Alcohol Programs, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC 29425, USA.
J Natl Med Assoc. 2007 May;99(5):564-9.
Liver cirrhosis mortality differs by ethnicity in the United States. Some studies suggest alcohol sensitivity may contribute to this finding. This analysis evaluated if alcohol-associated changes in aspartate aminotransferase (AST) and alanine transaminase (ALT) differed by ethnicity among heavy drinkers.
Subjects included 1691 subjects from Project MATCH, a multicenter alcohol use disorders treatment trial. Changes in AST and ALT over 15 months were modeled as functions of ethnicity, age, gender, time, study site and alcohol use. The main focus was on ethnic differences in changes in transaminase activity occurring with changes in alcohol use.
At all levels of alcohol consumption AST was lower in non-Hispanic whites relative to African Americans and Mexican Americans. Changes in AST associated with changes in alcohol use did not vary by ethnicity. ALT significantly differed only between Mexican Americans and non-Hispanic whites. Similar to AST, alcohol-associated ALT change did not differ by ethnicity.
Among individuals with alcohol use disorders participating in a treatment trial, the effect of alcohol drinking on transaminase activity did not vary by ethnicity. However, in the general population, alcohol may still interact with other factors in mediating ethnic differences in cirrhosis mortality.
在美国,肝硬化死亡率因种族而异。一些研究表明,酒精敏感性可能是导致这一结果的原因。本分析评估了重度饮酒者中,天冬氨酸转氨酶(AST)和丙氨酸转氨酶(ALT)与酒精相关的变化是否因种族而异。
研究对象包括来自多中心酒精使用障碍治疗试验“匹配计划”的1691名受试者。将15个月内AST和ALT的变化作为种族、年龄、性别、时间、研究地点和酒精使用情况的函数进行建模。主要关注饮酒量变化时转氨酶活性变化的种族差异。
在所有饮酒水平上,非西班牙裔白人的AST相对于非裔美国人和墨西哥裔美国人更低。与饮酒量变化相关的AST变化不因种族而异。ALT仅在墨西哥裔美国人和非西班牙裔白人之间存在显著差异。与AST相似,与酒精相关的ALT变化也不因种族而异。
在参与治疗试验的酒精使用障碍患者中,饮酒对转氨酶活性的影响不因种族而异。然而,在一般人群中,酒精在介导肝硬化死亡率的种族差异方面可能仍与其他因素相互作用。